Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1.74B
-
Number of holders
-
3114
-
Total 13F shares, excl. options
-
1.35B
-
Shares change
-
-20.1M
-
Total reported value, excl. options
-
$181B
-
Value change
-
-$2.76B
-
Put/Call ratio
-
0.83
-
Number of buys
-
1308
-
Number of sells
-
-1434
-
Price
-
$133.94
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q3 2025
3,329 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q3 2025.
ABBOTT LABORATORIES - Common Stock (ABT) has 3,114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.35B shares
of 1.74B outstanding shares and own 77.66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (173M shares), BlackRock, Inc. (142M shares), STATE STREET CORP (78.2M shares), Capital International Investors (61.6M shares), Capital Research Global Investors (38.8M shares), MORGAN STANLEY (38.6M shares), GEODE CAPITAL MANAGEMENT, LLC (38.5M shares), JPMORGAN CHASE & CO (29.4M shares), WELLINGTON MANAGEMENT GROUP LLP (23.2M shares), and BANK OF AMERICA CORP /DE/ (20.8M shares).
This table shows the top 3114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.